Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-01-02 @ 1:47 PM
Study NCT ID:
NCT04851535
Status:
COMPLETED
Last Update Posted:
2023-11-03
First Post:
2021-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZGJAK017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None